Bausch & Lomb
BLCO· Manufacturing· Fiscal year ends in December
Brenton L. Saunders is the CEO of Bausch & Lomb and was paid $32.2M in FY2025 (Dec), up 35%.
Executives5
See all- 1Brenton L. SaundersChairman of the Board and Chief Executive OfficerFY2025
- 2Sam A. EldessoukyExecutive Vice President and Chief Financial OfficerFY2025
- 3A. Robert D. BaileyExecutive Vice President and Chief Legal OfficerFY2025
- 4Dr. Yehia HashadExecutive Vice President of Research & Development and Chief Medical OfficerFY2025
- 5Andrew J. StewartPresident, Global Pharmaceuticals and International ConsumerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allBausch & Lomb paid its 5 named executives $46.1M in total in FY2025 (Dec). CEO Brenton L. Saunders was paid $32.2M of that.
| Name | |||
|---|---|---|---|
| Brenton L. SaundersChairman of the Board and Chief Executive Officer | |||
| Sam A. EldessoukyExecutive Vice President and Chief Financial Officer | |||
| A. Robert D. BaileyExecutive Vice President and Chief Legal Officer | |||
| Dr. Yehia HashadExecutive Vice President of Research & Development and Chief Medical Officer | |||
| Andrew J. StewartPresident, Global Pharmaceuticals and International Consumer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2025 (Dec) proxy of Bausch & Lomb names 15 peer companies for pay. Among Bausch & Lomb and these peers, CEO pay was the highest of 12 and total shareholder return was 5th highest of 12.
1st highest of 12in Bausch & Lomb and its pay peers, FY2025 (Dec) by CEO pay:
5th highest of 12in Bausch & Lomb and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 10, 2026 | FY2025 |
| Annual report | 10-K | Feb 18, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 10, 2025 | FY2024 |
| Annual report | 10-K | Feb 19, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 29, 2024 | FY2023 |
| Annual report | 10-K | Feb 21, 2024 | FY2023 |